S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.23%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.10%) $2 349.60
Silver
(-0.07%) $27.52
Platinum
(0.25%) $924.40
USD/EUR
(0.36%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Actualizaciones en tiempo real para CSL Ltd [CSL.AX]

Bolsa: ASX Industria: Pharmaceuticals, Biotechnology & Life Sciences
Última actualización26 abr 2024 @ 02:10

-1.85% $ 273.30

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 02:10):

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally...

Stats
Volumen de hoy 713 845
Volumen promedio 724 103
Capitalización de mercado 132.07B
EPS $0 ( 2024-02-13 )
Last Dividend $1.621 ( 2023-03-09 )
Next Dividend $0 ( N/A )
P/E 34.86
ATR14 $0.0970 (0.04%)

Volumen Correlación

Largo: 0.15 (neutral)
Corto: 0.17 (neutral)
Signal:(41.138) Neutral

CSL Ltd Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CSL Ltd Correlación - Moneda/Commodity

The country flag -0.32
( neutral )
The country flag -0.34
( neutral )
The country flag 0.00
( neutral )
The country flag -0.03
( neutral )
The country flag -0.29
( neutral )
The country flag -0.06
( neutral )

CSL Ltd Finanzas

Annual 2023
Ingresos: $19.59B
Beneficio Bruto: $9.47B (48.33 %)
EPS: $6.92
FY 2023
Ingresos: $19.59B
Beneficio Bruto: $9.47B (48.33 %)
EPS: $6.92
FY 2022
Ingresos: $14.47B
Beneficio Bruto: $7.68B (53.05 %)
EPS: $6.63
FY 2021
Ingresos: $10.27B
Beneficio Bruto: $5.80B (56.49 %)
EPS: $5.22

Financial Reports:

No articles found.

CSL Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$1.758
(N/A)
$0
(N/A)
$1.621
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

CSL Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.26 - Increase likely (45.22%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0167 1994-11-08
Last Dividend $1.621 2023-03-09
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 59 --
Total Paid Out $28.07 --
Avg. Dividend % Per Year 0.00% --
Score 4.48 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.26
Div. Directional Score 9.64 --
Next Divdend (Est)
(2024-06-24)
$0 Estimate 0.00 %
Dividend Stability
0.10 Very Bad
Dividend Score
4.48
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
YAL.AX Ex Dividend Knight 2023-09-05 Annually 0 0.00%
FGG.AX Ex Dividend Junior 2023-10-05 Annually 0 0.00%
PMV.AX Ex Dividend Knight 2023-06-20 Semi-Annually 0 0.00%
ARG.AX Ex Dividend Knight 2023-08-25 Semi-Annually 0 0.00%
IFL.AX Ex Dividend Junior 2023-09-07 Semi-Annually 0 0.00%
SDG.AX Ex Dividend Knight 2023-10-24 Quarterly 0 0.00%
CCP.AX Ex Dividend Knight 2023-09-18 Annually 0 0.00%
MCY.AX Ex Dividend Knight 2023-09-13 Semi-Annually 0 0.00%
TGF.AX Ex Dividend Junior 2023-09-07 Semi-Annually 0 0.00%
CUV.AX Ex Dividend Knight 2023-09-05 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1801.5006.419.61[0 - 0.5]
returnOnAssetsTTM0.06961.2007.689.21[0 - 0.3]
returnOnEquityTTM0.1561.5009.3810.00[0.1 - 1]
payoutRatioTTM0.450-1.0005.50-5.50[0 - 1]
currentRatioTTM2.150.8004.253.40[1 - 3]
quickRatioTTM0.9710.8009.007.20[0.8 - 2.5]
cashRatioTTM0.2161.5009.9110.00[0.2 - 2]
debtRatioTTM0.282-1.5005.30-7.95[0 - 0.6]
interestCoverageTTM6.971.0008.538.53[3 - 30]
operatingCashFlowPerShareTTM8.342.007.2210.00[0 - 30]
freeCashFlowPerShareTTM3.592.008.2110.00[0 - 20]
debtEquityRatioTTM0.612-1.5007.55-10.00[0 - 2.5]
grossProfitMarginTTM0.4841.0005.265.26[0.2 - 0.8]
operatingProfitMarginTTM0.2441.0007.127.12[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2611.0009.669.66[0.2 - 2]
assetTurnoverTTM0.3880.800-0.748-0.599[0.5 - 2]
Total Score12.02

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM34.661.0006.600[1 - 100]
returnOnEquityTTM0.1562.509.6010.00[0.1 - 1.5]
freeCashFlowPerShareTTM3.592.008.8010.00[0 - 30]
dividendYielPercentageTTM1.3931.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.342.007.2210.00[0 - 30]
payoutRatioTTM0.4501.5005.50-5.50[0 - 1]
pegRatioTTM7.921.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1901.0007.750[0.1 - 0.5]
Total Score7.26

CSL Ltd

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico